1ILMN logo

Illumina, Inc.BIT:1ILMN Stock Report

Market Cap €27.4b
Share Price
n/a
1Y114.7%
7D-1.3%
1D-3.0%
Portfolio Value
​
View

Illumina, Inc.

BIT:1ILMN Stock Report

Market Cap: €27.4b

Illumina (1ILMN) Stock Overview

Provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. More details

1ILMN fundamental analysis
Snowflake Score
Valuation2/6
Future Growth4/6
Past Performance2/6
Financial Health5/6
Dividends0/6

Rewards

Trading at 21.6% below our estimate of its fair value

Earnings are forecast to grow 12.29% per year

Risk Analysis

Volatile share price over the past 3 months compared to the Italian market

Large one-off items impacting financial results

Profit margins (18.3%) are lower than last year (28.8%)

Significant insider selling over the past 3 months


1ILMN Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW435,612 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.
Grow your followingReal investors. The kind who actually invest, not scroll past.
Unlock free accessFree premium subscription for consistent and quality authors.
Learn moreCreate Narrative
B
BlackGoat
R
RockeTeller
I
Investingwilly
D
davidlsander
435,612 investors already sharing narratives
View all narratives

Illumina, Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Illumina
Historical stock prices
Current Share PriceUS$178.54
52 Week HighUS$193.36
52 Week LowUS$77.12
Beta1.47
1 Month Change8.26%
3 Month Change26.30%
1 Year Change114.67%
3 Year Change24.89%
5 Year Change-53.00%
Change since IPO-37.71%

Recent News & Updates

Recent updates

Shareholder Returns

1ILMNIT Life SciencesIT Market
7D-1.3%-4.4%0.0009%
1Y114.7%3.8%19.2%

Return vs Industry: 1ILMN exceeded the Italian Life Sciences industry which returned 4.2% over the past year.

Return vs Market: 1ILMN exceeded the Italian Market which returned 20.1% over the past year.

Price Volatility

Is 1ILMN's price volatile compared to industry and market?
1ILMN volatility
1ILMN Average Weekly Movement6.5%
Life Sciences Industry Average Movement5.7%
Market Average Movement4.1%
10% most volatile stocks in IT Market7.3%
10% least volatile stocks in IT Market2.6%

Stable Share Price: 1ILMN's share price has been volatile over the past 3 months compared to the Italian market.

Volatility Over Time: 1ILMN's weekly volatility (6%) has been stable over the past year, but is still higher than 75% of Italian stocks.

About the Company

FoundedEmployeesCEOWebsite
19988,625Jacob Thaysenwww.illumina.com

Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services.

Illumina, Inc. Fundamentals Summary

How do Illumina's earnings and revenue compare to its market cap?
1ILMN fundamental statistics
Market cap€27.40b
Earnings (TTM)€708.48m
Revenue (TTM)€3.86b
37.6x
P/E Ratio
6.9x
P/S Ratio

Is 1ILMN overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
1ILMN income statement (TTM)
RevenueUS$4.49b
Cost of RevenueUS$1.44b
Gross ProfitUS$3.05b
Other ExpensesUS$2.23b
EarningsUS$824.00m

Last Reported Earnings

Jun 28, 2026

Next Earnings Date

n/a

Earnings per share (EPS)5.46
Gross Margin67.94%
Net Profit Margin18.34%
Debt/Equity Ratio70.2%

How did 1ILMN perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/09/09 06:19
End of Day Share Price 2026/09/09 00:00
Earnings2026/06/28
Annual Earnings2025/12/28

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Illumina, Inc. is covered by 48 analysts. 19 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jasper HellwegArgus Research Company
Catherine Ramsey SchulteBaird
Robert BambergerBaird